Answers are grounded in this paper and cite their sources.
Retrospective analysis compares UBE-TLIF and MIS-TLIF for lumbar spinal brucellosis, indicating surgical preference benefits.
Objective This study aimed to compare the clinical efficacy and safety of unilateral biportal endoscopy-assisted transforaminal lumbar interbody fusion (UBE-TLIF) vs. minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of lumbar spinal brucellosis, with the goal of identifying an optimized surgical strategy. Methods A retrospective analysis was conducted on 62 patients with lumbar spinal brucellosis who underwent surgery between January 2018 and June 2024. Patients were divided into two groups based on the surgical approach: UBE-TLIF ( n = 32) and MIS-TLIF ( n = 30). Baseline characteristics, perioperative parameters (operative time, estimated blood loss, incision length, hospital stay), inflammatory markers [Brucella agglutination titer, erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], procalcitonin [PCT]], pain scores [visual analog scale (VAS) for back and leg pain], functional outcomes [Oswestry Disability Index (ODI)], intervertebral disc height, complications, bone fusion rate, and MacNab criteria were compared between groups. Results The two groups were comparable in baseline characteristics ( P > 0.05). The UBE-TLIF group demonstrated significantly shorter operative time and hospital stay, less intraoperative blood loss, and smaller incisions ( P < 0.05). Postoperative inflammatory markers decreased significantly in both groups ( P < 0.05), with no significant intergroup differences ( P > 0.05). The UBE-TLIF group had significantly lower VAS scores at 1 and 3 months postoperatively ( P < 0.05), but these differences resolved by 6 months and final follow-up ( P > 0.05). Both groups showed significant improvements in ODI and intervertebral disc height postoperatively ( P < 0.05), with no intergroup differences ( P > 0.05). Complications included three dural tears (UBE-TLIF) and four nerve root injuries (MIS-TLIF), all managed conservatively, with comparable complication rates ( P > 0.05). Mean follow-up was 18.5 ± 3.6 months in the UBE-TLIF group and 18.1 ± 3.9 months in the MIS-TLIF group ( P > 0.05). No recurrence or implant-related complications occurred. Bone fusion rates (96.88% vs. 93.33%) and MacNab excellent/good rates (93.75% vs. 90.00%) were similar between groups ( P > 0.05). Conclusion Both UBE-TLIF and MIS-TLIF are safe and effective surgical options for lumbar spinal brucellosis, providing adequate infection control, pain relief, functional restoration, and satisfactory bone fusion. UBE-TLIF offers superior minimally invasive benefits, including shorter operative time, reduced blood loss, less surgical trauma, and enhanced early postoperative pain control, supporting its preferential application in appropriately selected patients by surgeons with relevant expertise.
No takes yet. Share an insight, caveat, or question.
Rui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: